Surgery Partners (NASDAQ:SGRY) Reaches New 12-Month High – Time to Buy?

Posted by Francis Steltz on Nov 5th, 2026

Surgery Partners, Inc. (NASDAQ:SGRY – Get Free Report) reached a new 52-week high during mid-day trading on Tuesday. The stock traded as high as $23.39 and last traded at $23.1910, with a volume of 5,487 shares trading hands. The stock had previously closed at $23.12.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the company. Raymond James Financial set a $23.50 target price on Surgery Partners in a report on Monday, October 26th. Weiss Ratings upgraded Surgery Partners from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, October 16th. Stonex Financial downgraded shares of Surgery Partners from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 27th. Zacks Research cut Surgery Partners from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 10th. Finally, TD Cowen downgraded Surgery Partners from a “strong-buy” rating to a “hold” rating in a report on Saturday, October 31st. Three investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $20.14.

Check Out Our Latest Stock Report on Surgery Partners

Surgery Partners Stock Performance

The business has a fifty day simple moving average of $15.67 and a 200-day simple moving average of $14.75. The company has a quick ratio of 1.78, a current ratio of 1.95 and a debt-to-equity ratio of 1.18. The firm has a market cap of $3.03 billion, a P/E ratio of -33.09 and a beta of 1.85.

Surgery Partners (NASDAQ:SGRY – Get Free Report) last announced its quarterly earnings data on Monday, August 10th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.06 by $0.04. The business had revenue of $848.90 million during the quarter, compared to analyst estimates of $830.03 million. Surgery Partners had a positive return on equity of 0.88% and a negative net margin of 2.63%. The company’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same quarter last year, the firm posted $0.17 earnings per share. On average, sell-side analysts predict that Surgery Partners, Inc. will post 0.07 EPS for the current fiscal year.

Insider Buying and Selling

In other Surgery Partners news, Director Teresa DeLuca acquired 10,000 shares of the business’s stock in a transaction on Tuesday, August 18th. The shares were acquired at an average price of $14.35 per share, for a total transaction of $143,500.00. Following the completion of the acquisition, the director owned 66,843 shares in the company, valued at $959,197.05. This trade represents a 17.59% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 2.00% of the stock is owned by insiders.

Hedge Funds Weigh In On Surgery Partners

Large investors have recently made changes to their positions in the business. Vise Technologies Inc. bought a new stake in shares of Surgery Partners during the third quarter valued at approximately $191,000. State of Wyoming raised its holdings in Surgery Partners by 51.4% in the 3rd quarter. State of Wyoming now owns 23,568 shares of the company’s stock worth $327,000 after acquiring an additional 7,997 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in Surgery Partners in the 3rd quarter worth approximately $426,000. Inspire Investing LLC boosted its stake in Surgery Partners by 10.1% during the 3rd quarter. Inspire Investing LLC now owns 44,768 shares of the company’s stock valued at $621,000 after purchasing an additional 4,099 shares during the last quarter. Finally, TD Waterhouse Canada Inc. boosted its stake in Surgery Partners by 18.3% during the 3rd quarter. TD Waterhouse Canada Inc. now owns 196,887 shares of the company’s stock valued at $2,601,000 after purchasing an additional 30,476 shares during the last quarter.

Surgery Partners Company Profile

(Get Free Report)

Surgery Partners, Inc is a U.S.-based healthcare services company that operates and manages ambulatory surgery centers and surgical hospitals. The company works with physicians, health systems and other healthcare providers to deliver outpatient surgical care in facilities designed for same-day procedures.

Its facilities provide surgical services across specialties such as orthopedics, pain management, ophthalmology, gastroenterology, urology, gynecology and general surgery. Surgery Partners also supports its operations with clinical, administrative and revenue-cycle services intended to help physicians and facility partners manage patient care and practice operations.

Founded in 2004 and headquartered in Brentwood, Tennessee, Surgery Partners has expanded its platform through acquisitions, joint ventures and other partnerships.